6 days Legend Biotech Reverses After J&J-Tied Cancer Drug Cuts Risk Of Death By 45% Investor's Business Daily
Legend Biotech reversed early gains Monday after the company said its J&J-tied multiple myeloma drug, Cavykti, cut the risk of death.
The post Legend Biotech Reverses After J&J-Tied Cancer Drug Cuts Risk Of Death By 45% appeared first on Inve…
Biotech · Johnson & Johnson (JNJ)